BioNTech SE

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.

About BNTX

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. 

CEO
Ugur Sahin
CEOUgur Sahin
Employees
7,807
Employees7,807
Headquarters
Mainz, Rheinland-Pfalz
HeadquartersMainz, Rheinland-Pfalz
Founded
2008
Founded2008
Employees
7,807
Employees7,807

BNTX Key Statistics

Market cap
25.63B
Market cap25.63B
Price-Earnings ratio
-13.01
Price-Earnings ratio-13.01
Dividend yield
Dividend yield
Average volume
2.57M
Average volume2.57M
High today
$111.91
High today$111.91
Low today
$94.01
Low today$94.01
Open price
$102.26
Open price$102.26
Volume
3.07M
Volume3.07M
52 Week high
$124.00
52 Week high$124.00
52 Week low
$79.52
52 Week low$79.52

BNTX News

TipRanks 13h
BioNTech SE Slides as Bold HIV Bet Takes Shape

BioNTech SE ( (BNTX) ) has fallen by -9.52%. Read on to learn why. BioNTech SE shares fell 9.52% over the past week, even as the company signaled progress in ex...

TipRanks 1d
BioNTech Stock Is Tumbling on Friday – Here’s Why

BioNTech (BNTX) shares declined as much as 10% on Friday after the company said it has ended a key Phase 2 trial for its mRNA colorectal cancer vaccine. The stu...

Benzinga 1d
BioNTech Stock Dips After BNT122-01 Trial Termination

BioNTech SE (NASDAQ:BNTX) shares are dropping Friday after the company announced it will terminate its Phase 2 clinical trial of autogene cevumeran in resected...

BioNTech Stock Dips After BNT122-01 Trial Termination

Analyst ratings

71%

of 21 ratings
Buy
71.4%
Hold
23.8%
Sell
4.8%

More BNTX News

TipRanks 2d
BioNTech Halts Phase 2 mRNA Monotherapy Trial in Resected Colorectal Cancer After DSMB Review

BioNTech SE ( (BNTX) ) has shared an update. On August 28, 2026, BioNTech SE announced it is terminating its Phase 2 BNT122-01 trial of autogene cevumeran, an...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.